Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X։
”The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction․
CMD is an independent predictor for future adverse outcomes in the HFpEF population.
CMD and HFpEF share pathophysiological links, although a direct causal relationship remains unproven.
Comprehensive CMD assessment in HFpEF can improve risk stratification and guide targeted therapeutic strategies.”
Read the full article here.

Article: The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Authors: Andreas Tzoumas, Danielle Tapp, Daniela Crousillat, Michael C. Honigberg, Patricia F. Rodriguez-Lozano, Niti R. Aggarwal, Imo A. Ebong, Joan Briller, Glaucia Moraes De Oliveira, Colleen M. Harrington, Selma F. Mohammed, Noel Bairey Merz, Timothy D. Henry, and Odayme Quesada
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026